<?xml version = '1.0' encoding = 'UTF-8'?>
<?xml-stylesheet href="/rss/styledrssBMC.css" type="text/css"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:extra="http://www.biomedcentral.com/xml/schemas/extra/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:cc="http://web.resource.org/cc/">
	<channel rdf:about="http://www.biomedcentral.com/rss">
		<extra:info rdf:parseType="Literal">
			<html:div xmlns:html="http://www.w3.org/1999/xhtml" style="font:14px Verdana, Geneva, Arial, Helvetica, sans-serif">
				<html:span style="font-weight:bold">This is an RSS newsfeed from BioMed Central</html:span>
				<html:br/>
				<html:span style="font-size: 12px;">It is intended to be used with an RSS reader. For more information about RSS newsfeeds from BioMed Central, visit <html:br/><html:a href="http://www.biomedcentral.com/info/about/rss/" style="color:#3333CC; font-size:12px;">http://www.biomedcentral.com/info/about/rss/</html:a><html:br/>
				</html:span>
			</html:div>
		</extra:info>
		<title>BMC Complementary and Alternative Medicine - Latest articles</title>
		<link>http://www.biomedcentral.com/bmccomplementalternmed/</link>
		<description>The latest articles from BMC Complementary and Alternative Medicine (ISSN 1472-6882) published by 
				
				BioMed Central
		</description>
        <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        <items>
            <rdf:Seq>
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/21"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/20"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/19"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/18"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/17"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/16"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/15"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/14"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/13"/>			    
            
				    <rdf:li rdf:resource="http://www.biomedcentral.com/1472-6882/8/12"/>			    
            
            </rdf:Seq>
        </items>
    </channel>  
    
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/21">
            
            <title>Effect of exercise therapy on lipid profile and oxidative stress indicators in patients with type 2 diabetes 

</title>
			<description>Background:
Yoga has been shown to be a simple and economical therapeutic modality that may be considered as a beneficial adjuvant for type 2 diabetes mellitus.  This study investigated the impact of Hatha yoga and conventional physical training (PT) exercise regimens on biochemical, oxidative stress indicators and oxidant status in patients with type 2 diabetes.
Methods:
This prospective randomized study consisted of 77 type 2 diabetic patients in the Hatha yoga exercise group that were matched with a similar number of type 2 diabetic patients in the conventional PT exercise and control groups.  Biochemical parameters such as fasting blood glucose (FBG), serum total cholesterol (TC), triglycerides, low-density lipoprotein (LDL), very low-density lipoproteins (VLDL) and high-density lipoprotein (HDL) were determined at baseline and at two consecutive three monthly intervals.  The oxidative stress indicators (malondialdehyde - MDA, protein oxidation - POX, phospholipase A2 - PLA2 activity) and oxidative status [superoxide dismutase (SOD) and catalase activities] were measured. 
Results:
The concentrations of FBG in the Hatha yoga and conventional PT exercise groups after six months decreased by 29.48% and 27.43% respectively (P &lt; 0.0001) and there was a significant reduction in serum TC in both groups (P &lt; 0.0001).  The concentrations of VLDL in the managed groups after six months differed significantly from baseline values (P = 0.036).  Lipid peroxidation as indicated by MDA significantly decreased by 19.9% and 18.1% in the Hatha yoga and conventional PT exercise groups respectively (P &lt; 0.0001); whilst the activity of SOD significantly increased by 24.08% and 20.18% respectively (P = 0.031).  There was no significant difference in the baseline and 6 months activities of PLA2 and catalase after six months although the latter increased by 13.68% and 13.19% in the Hatha yoga and conventional PT exercise groups respectively (P = 0.144).  
Conclusion:
The study demonstrate the efficacy of Hatha yoga exercise on fasting blood glucose, lipid profile, oxidative stress markers and antioxidant status in patients with type 2 diabetes and suggest that Hatha yoga exercise and conventional PT exercise may have therapeutic preventative and protective effects on diabetes mellitus by decreasing oxidative stress and improving antioxidant status. 
Trial Registration: Australian New Zealand Clinical Trials Registry (ANZCTR): ACTRN12608000217303</description>
			<link>http://www.biomedcentral.com/1472-6882/8/21</link>
			
			 	<dc:creator>Lorenzo A Gordon, Errol Y Morrison, Donovan A McGrowder, Ronald Young, Yeiny P Fraser, Eslaen M Zamoraz, Ruby L Alexander-Lindo and Rachael R Irving</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:21</dc:source>
			<dc:date>2008-05-13</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-21</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>21</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-13</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/20">
            
            <title>Electroacupuncture activates corticotrophin-releasing hormone-containing neurons in the paraventricular nucleus of the hypothalammus to alleviate edema in a rat model of inflammation</title>
			<description>Background:
Studies show that electroacupuncture (EA) has beneficial effects in patients with inflammatory diseases. This study investigated the mechanisms of EA anti-inflammation, using a rat model of complete Freund's adjuvant (CFA)-induced hind paw inflammation and hyperalgesia. DesignFour experiments were conducted on male Sprague-Dawley rats (n=6-7/per group). Inflammation was induced by injecting CFA into the plantar surface of one hind paw. Experiment 1 examined whether EA increases plasma adrenocorticotropic hormone (ACTH) levels. Experiments 2 and 3 studied the effects of the ACTH and corticotropin-releasing hormone (CRH) receptor antagonists, ACTH (11-24) and astressin, on the EA anti-edema. Experiment 4 determined whether EA activates CRH neurons in the paraventricular nucleus of the hypothalammus. EA treatment, 10 Hz at 3 mA and 0.1 ms pulse width, was given twice for 20 min each, once immediately post and again 2 hr post-CFA. Plasma ACTH levels, paw thickness, and paw withdrawal latency to a noxious thermal stimulus were measured 2 h and 5 h after the CFA. 
Results:
EA significantly increased ACTH levels 5 h (2 folds) after CFA compared to sham EA control, but EA alone in naive rats and CFA alone did not induce significant increases in ACTH. ACTH (11-24) and astressin blocked EA anti-edema but not EA anti-hyperalgesia. EA induced phosphorylation of NR1, an essential subunit of the N-methyl-D-aspartic acid (NMDA) receptor, in CRH-containing neurons of the paraventricular nucleus. 
Conclusion:
The data demonstrate that EA activates CRH neurons to significantly increase plasma ACTH levels and suppress edema through CRH and ACTH receptors in a rat model of inflammation. </description>
			<link>http://www.biomedcentral.com/1472-6882/8/20</link>
			
			 	<dc:creator>Aihui Li, Lixing Lao, Yi Wang, Jiajia Xin, Ke Ren, Brian M. Berman, Ming Tan and Ruixin Zhang</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:20</dc:source>
			<dc:date>2008-05-12</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-20</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>20</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-12</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/19">
            
            <title>Prospective investigation of complementary and alternative medicine use and subsequent hospitalizations
</title>
			<description>Background:
The prevalence of complementary and alternative medicine (CAM) use has been estimated to be as high as 65% in some populations. However, there has been little objective research into the possible risks or benefits of unmanaged CAM therapies.  
Methods:
In this prospective study of active duty US Navy and Marine Corps personnel, the association between self-reported practitioner-assisted or self-administered CAM use and future hospitalization was investigated.  Cox regression models were used to examine risk of hospitalization due to any cause over the follow-up period from date of questionnaire submission, until hospitalization, separation from the military, or end of observation period (June 30, 2004), whichever occurred first.
Results:
After adjusting for baseline health, baseline trust and satisfaction with conventional medicine, and demographic characteristics, those who reported self-administering two or more CAM therapies were significantly less likely to be hospitalized for any cause when compared with those who did not self-administer CAM (HR=0.38; 95% CI=0.17, 0.86).  Use of multiple practitioner-assisted CAM was not associated with a significant decrease or increase of risk for future hospitalization (hazards ratio=1.86; 95 percent confidence interval= 0.96-3.63).
Conclusions:
While there were limitations to these analyses, this investigation utilized an objective measure of health to investigate the potential health effects of CAM therapies and found a modest reduction in the overall risk of hospitalization associated with self-administration of two or more CAM therapies.  In contrast, use of practitioner-assisted CAM was not associated with a protective effect.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/19</link>
			
			 	<dc:creator>Tyler C Smith, Besa Smith and Margaret AK Ryan</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:19</dc:source>
			<dc:date>2008-05-08</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-19</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>19</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-08</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/18">
            
            <title>The effect of acupuncture duration on analgesia and peripheral sensory thresholds</title>
			<description>Background:
Acupuncture provides a means of peripheral stimulation for pain relief. However, the detailed neuronal mechanisms by which acupuncture relieves pain are still poorly understood and information regarding optimal treatment settings is still inadequate. Previous studies with a short burst of unilateral electroacupuncture (EA) in the Tendinomuscular Meridians (TMM) treatment model for pain demonstrated a transient dermatomally correlated bilateral analgesic effect with corresponding peripheral modality-specific sensory threshold alterations. However, the impact of EA duration on the analgesic effect in this particular treatment model is unknown. To obtain mechanistically and clinically important information regarding EA analgesia, this current prospective cross-over study assesses the effects of EA duration on analgesia and thermal sensory thresholds in the TMM treatment model.
Methods:
Baseline peripheral sensory thresholds were measured at pre-marked testing sites along the medial aspects (liver and spleen meridians) of bilateral lower extremities. A 5-second hot pain stimulation was delivered to the testing sites and the corresponding pain Visual Analog Scale (VAS) scores were recorded. Three different EA (5Hz) stimulation durations (5, 15 and 30 minutes) were randomly tested at least one week apart. At the last 10 seconds of each EA session, 5 seconds of subject specific HP stimulation was delivered to the testing sites. The corresponding pain and EA VAS scores of de qi sensation (tingling) during and after the EA were recorded. The measurements were repeated immediately, 30 and 60 minutes after the EA stimulation. A four-factor repeat measures ANOVA was used to assess the effect of stimulation duration, time, location (thigh vs. calf) and side (ipsilateral vs. contralateral) of EA on sensory thresholds and HP VAS scores.
Results:
A significant (P &lt; 0.01) main effect of time and location with warm, cold and hot pain thresholds at the four testing sites without any significant difference in duration effect was observed. Similar time and location effects were observed with HP VAS with the longer durations (15 and 30 minutes) of stimulation showed a slower onset, but a more sustainable bilateral analgesic benefit than the short stimulation duration (5 minutes). The 15-minute stimulation resulted in an earlier onset of analgesic effect than the 30-minute stimulation paradigm.
Conclusion:
Longer durations of EA stimulation provide a more sustainable analgesic benefit to hot noxious stimulation than a shorter duration of stimulation. The increase of cold threshold with sustained warm threshold temperature elevation as observed in the longer durations of EA suggests that as the duration of EA lengthened, there is a gradual shifting from an initial predominantly spinally mediated analgesic effect to a supraspinally mediated modulatory mechanism of thermal pain. The 15-minute stimulation appeared to be the optimal setting for treating acute pain in the lower extremities.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/18</link>
			
			 	<dc:creator>Albert Y Leung, Susan J Kim, Gery Schulteis and Tony Yaksh</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:18</dc:source>
			<dc:date>2008-05-01</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-18</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>18</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-05-01</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/17">
            
            <title>Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer</title>
			<description>Background:
Complementary and alternative medicine (CAM) use is well documented among breast cancer patients and survivors, but little evidence is available to describe rates and patterns of use among women at increased genetic risk of breast cancer.  
Methods:
A pre-visit telephone interview was conducted to ascertain CAM use among the BRCA mutation carriers enrolled in a high-risk breast cancer screening study.  Participants were asked to report on their use of thirteen therapies within the year prior to enrollment into the study.  Logistic regression was used to evaluate the association between various factors and CAM use in this population.
Results:
Among the 164 BRCA1 or BRCA2 mutation-positive (BRCA+) women in this analysis, 78% reported CAM use, with prayer and lifestyle diet being the two most commonly reported modalities.  Many subjects used multiple CAM therapies, with 34% reporting use of three or more modalities.   The most commonly used modalities were mind-body therapies and biologically-based practices, 61.6% and 51.8%, respectively.  High-risk women were more likely to use CAM if they were older, more educated, more worried about ovarian cancer risk, or had a previous cancer diagnosis.
Conclusions:
This study suggests that the prevalence of CAM use is high among BRCA mutation carriers, with frequency of use comparable to that of breast cancer patients and survivors.  Given the high prevalence of CAM use in our subjects, especially biologically-based therapies including herbal supplements, whose safety and efficacy in relation to cancer risk are unknown, our study suggests that future research is necessary to clarify these risks, and that it is important for providers to inquire about and to discuss the pros and cons of CAM use with their BRCA+ patients.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/17</link>
			
			 	<dc:creator>Christine M Mueller, Phuong L Mai, Jaime Bucher, June A Peters, Jennifer T Loud and Mark H Greene</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:17</dc:source>
			<dc:date>2008-04-30</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-17</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>17</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-30</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/16">
            
            <title>Motivations for consulting complementary and alternative medicine practitioners: A comparison of consumers from 1997-8 and 2005</title>
			<description>Background:
Use of complementary and alternative medicine (CAM), and especially CAM practitioners, has continued to rise in recent years. Although several motivators of CAM use have been identified, little is known about how and if the motivations for using CAM have changed over time. The purpose of the current study was to compare the reasons for consulting CAM practitioners in consumers in 1997-8 and eight years later in 2005. 
Methods:
Surveys were displayed in CAM and conventional medicine offices and clinics in Ontario, Canada in 1997-8 and again in 2005, and self-selected participants returned the surveys by mail.
Results:
In 1997-8, 141 CAM consumers were identified from the 199 surveys returned, and 185 CAM consumers were identified from the 239 surveys returned in 2005. Five of the six CAM motivations were more likely to be endorsed by the 2005 CAM consumers compared to the 1997-8 CAM consumers (all p's &lt; .0001). In 1997-8 the two top reasons for using CAM were that CAM allowed them to take an active role in their health (51.8%), and because conventional medicine was ineffective for their health problem (41.8%). In 2005, the treatment of the whole person (78.3%) was the top reason for using CAM followed by taking an active role in oneas health (76.5%). The 2005 consumers were less educated, had slightly more chronic health complaints, had been using CAM for longer, and were more likely to consult chiropractors, reflexologists, and therapeutic touch practitioners than the 1997-8 consumers. Otherwise, the socio-demographic and health profiles of the two groups of CAM consumers were similar, as was their use of CAM. 
Conclusions:
Compared to consumers in 1997-8, consumers in 2005 were more likely to endorse five of the six motivations for consulting CAM practitioners. A shift towards motivations focusing more on the positive aspects of CAM and less on the negative aspects of conventional medicine was also noted for the 2005 consumers. Findings suggest that CAM motivations may shift over time as public knowledge of and experience with CAM also changes.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/16</link>
			
			 	<dc:creator>Fuschia M. Sirois</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:16</dc:source>
			<dc:date>2008-04-29</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-16</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>16</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-29</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/15">
            
            <title>Evaluation of behavioural and antioxidant activity of Cytisus scoparius Link in rats exposed to chronic unpredictable mild stress</title>
			<description>Background:
Various human diseases have oxidative stress as one of their component. Many herbs have been reported to exhibit properties that combat oxidative stress through their active constituents such as flavonoids, tannins, phenolic compounds etc. Cytisus scoparius (CS) Link, (Family: Leguminosae), also called Sarothamnus scoparius, has been shown in invitro experiments to be endowed with anti-diabetic, hypnotic and sedative and antioxidant activity. Therefore this study was carried out to evaluate CS for its anxiolytic, antidepressant and anti-oxidant activity in stressed rats.
Methods:
60% methanolic extract of CS was quantified for phenolic content by Folin-Ciocalteau's method. Chronic unpredictable mild stress (CMS) was employed to induce stress in rats. CS (125 and 250 mg/kg, p.o) and diazepam (DZM) (2 mg/kg, p.o) was administered during the 21 day stress exposure period. Anxiolytic and antidepressant activities of CS were assessed in open field exploratory and behavioural despair paradigms, respectively. Plasma glucose and total lipids; endogenous antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT); non-enzymic-ascorbic acid and thiobarbituric acid reactive substances (TBARS) levels were measured in brain, kidneys and adrenals using standard protocols to assess the effect of CS.
Results:
Total phenolic content of CS was found to be 8.54 &#177; 0.16% w/w. CMS produced anxiogenic and depressive behaviour in experimental rats with metabolic disturbance. Significant decrease in SOD, CAT levels and increase in lipid peroxidation level was observed in stressed rats. CS administration for 21 days during stress exposure significantly increased the ambulatory behaviour and decreased the freezing time in open field behaviour. In behavioural despair test no significant alteration in the immobility period was observed. CS also improved SOD, CAT, and ascorbic acid level and controlled the lipid peroxidation in different tissues.
Conclusion:
CS possesses anti-stress and moderate anxiolytic activity which may be due, in part, to its antioxidant effect that might warrant further studies.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/15</link>
			
			 	<dc:creator>Jayabalan Nirmal, Chidambaram Saravana Babu, Thanukrishnan Harisudhan and Muthiah Ramanathan</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:15</dc:source>
			<dc:date>2008-04-24</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-15</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>15</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-24</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/14">
            
            <title>Patterns of complementary and alternative medicine use amongst outpatients in Tokyo, Japan</title>
			<description>Background:
The use of complementary and alternative medicine (CAM) has been increasing rapidly throughout the world during the past decade. The use of CAM in the general Japanese population has been previously reported to be as high as 76%. This study aims to investigate the patterns of CAM use, perceived effectiveness and disclosure of CAM use to orthodox medical practitioners amongst patients attending typical primary and secondary care clinics in a busy district general hospital in Tokyo, Japan.
Methods:
The authors analysed data collected during March 2002 on patients attending general outpatient clinics held at Shiseikai Daini Hospital in Tokyo, Japan. Data was collected by use of self-completed questionnaires distributed to patients in the outpatient clinics waiting area. Statistical analysis was performed using chi-square tests of independence.
Results:
515 adults were approached to participate in this study and the overall response rate was 96% (n = 496). 50% of the patients were using or have used at least 1 CAM therapy within the last 12 months. The 5 most commonly used therapies were massage (n = 106, 43%), vitamins (n = 85, 35%), health foods including dietary supplements (n = 56, 23%), acupressure (n = 51, 21%) and kampo (n = 46, 19%). The majority of CAM users (75%, n = 145) found their CAM treatment to be effective (95% CI = 68&#8211;81%). Patients who were more likely to use CAM were females (p = 0.003) and those with a high number of medical conditions (p = &lt; 0.0001). Only a small proportion of patients reported their CAM use to their physician (42%, n = 74). There was no significant difference in CAM use for the different age groups (p = 0.85), education level (p = 0.30) and financial status (p = 0.82).
Conclusion:
Patterns of CAM usage in the sample surveyed was high (50%). Despite this high prevalence rate and presumed acceptance of CAM in Japan, the reporting of CAM use by patients to their physicians was low (42%). It is therefore important that physicians are aware of the possibility that their patients may be using CAM and also increase their knowledge and understanding of these treatments.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/14</link>
			
			 	<dc:creator>Satoshi Hori, Iordan Mihaylov, Joana C Vasconcelos and Malcolm McCoubrie</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:14</dc:source>
			<dc:date>2008-04-23</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-14</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>14</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-23</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/13">
            
            <title>A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis</title>
			<description>Background:
Allergies cause a considerable burden to both sufferers and the National Health Service. There is growing interest in acupuncture as a treatment for a range of conditions. Since acupuncture may modulate the immune system it could be a useful treatment for allergic rhinitis (AR) sufferers. We therefore assessed the evidence for the clinical effectiveness of acupuncture in patients with AR by performing a systematic review of the literature.
Methods:
Searches (to 2007) were conducted in all major databases for randomised controlled trials (RCTs) evaluating the clinical effectiveness of acupuncture in the treatment of AR. No limits were placed on language. Studies were included if they compared acupuncture to a sham or inactive acupuncture treatment (placebo) with or without standard care. Meta-analysis was performed where feasible.
Results:
Seven relevant RCTs were included after screening and application of inclusion and exclusion criteria. The trials were generally of poor quality as assessed by a modified Jadad scale, with the exception of two studies which scored highly. A wide variety of outcomes was measured but most assessed symptom severity on a visual analogue scale. A meta-analysis failed to show any summary benefits of acupuncture treatment for symptom severity scores or serum IgE measures which could not have been accounted for by chance alone. Acupuncture was not associated with any additional adverse events in the trials.
Conclusion:
There is currently insufficient evidence to support or refute the use of acupuncture in patients with AR. A large well conducted RCT, which overcomes identified methodological problems in the existing RCTs, would be required to resolve this question.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/13</link>
			
			 	<dc:creator>Jonathan Roberts, Aarnoud Huissoon, Janine Dretzke, Dechao Wang and Christopher Hyde</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:13</dc:source>
			<dc:date>2008-04-22</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-13</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>13</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-22</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
	
		<item rdf:about="http://www.biomedcentral.com/1472-6882/8/12">
            
            <title>Study protocol for a pragmatic randomised controlled trial in general practice investigating the effectiveness of acupuncture against migraine</title>
			<description>Background:
Migraine is a chronic neurologic disease that can severely affect the patient's quality of life. Although in recent years many randomised studies have been carried out to investigate the effectiveness of acupuncture as a treatment for migraine, it remains a controversial issue. Our aim is to determine whether acupuncture, applied under real conditions of clinical practice in the area of primary healthcare, is more effective than conventional treatment.Methods/DesignThe design consists of a pragmatic multi-centre, three-armed randomised controlled trial, complemented with an economic evaluation of the results achieved, comparing the effectiveness of verum acupuncture with sham acupuncture, and with a control group receiving normal care only.Patients eligible for inclusion will be those presenting in general practice with migraine and for whom their General Practitioner (GP) is considering referral for acupuncture. Sampling will be by consecutive selection, and by randomised allocation to the three branches of the study, in a centralised way following a 1:1:1 distribution (verum acupuncture; sham acupuncture; conventional treatment). Secondly, one patient in three will be randomly selected from each of the acupuncture (verum or sham) groups for a brain perfusion study (by single photon emission tomography). The treatment with verum acupuncture will consist of 8 treatment sessions, once a week, at points selected individually by the acupuncturist. The sham acupuncture group will receive 8 sessions, one per week, with treatment being applied at non-acupuncture points in the dorsal and lumbar regions, using the minimal puncture technique. The control group will be given conventional treatment, as will the other two groups.DiscussionThis trial will contribute to available evidence on acupuncture for the treatment of migraine. The primary endpoint is the difference in the number of days with migraine among the three groups, between the baseline period (the 4 weeks prior to the start of treatment) and the period from weeks 9 to 12. As a secondary aspect, we shall record the index of laterality and the percentage of change in the mean count per pixel in each region of interest measured by the brain perfusion tomography, performed on a subsample of the patients within the real and sham acupuncture groups.Trial registrationCurrent Controlled Trials ISRCTN98703707.</description>
			<link>http://www.biomedcentral.com/1472-6882/8/12</link>
			
			 	<dc:creator>Jorge Vas, &#193;ngel Rebollo, Emilio Perea-Milla, Camila M&#233;ndez, Carlos Ramos Font, Manuel G&#243;mez-R&#237;o, Manuel Mart&#237;n-&#193;vila, Justo Carbrera-Ibole&#243;n, M Dolores Caballero, M &#193;ngeles Olmos, Inmaculada Aguilar, Vicente Faus and Francisco Martos</dc:creator>
			
			<dc:source>BMC Complementary and Alternative Medicine 2008, 8:12</dc:source>
			<dc:date>2008-04-14</dc:date>
			<dc:identifier>doi:10.1186/1472-6882-8-12</dc:identifier>
			
			
							
					<prism:publicationName>BMC Complementary and Alternative Medicine</prism:publicationName>
					
			
							
					<prism:issn>1472-6882</prism:issn>
					
			
							
					<prism:volume>8</prism:volume>
					
			
							
					<prism:startingPage>12</prism:startingPage>
					
			
							
					<prism:publicationDate>2008-04-14</prism:publicationDate>
					

            <cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
        </item>
		
    <cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
         <cc:permits rdf:resource="http://creativecommons.org/ns#Reproduction"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#Distribution"/>
         <cc:permits rdf:resource="http://creativecommons.org/ns#DerivativeWorks"/>
	</cc:License>
</rdf:RDF>
